Ketotifen Fumarate Ophthalmic |
ketotifen fumarate; Zaditor |
Article: Ketotifen
![]() | |
| Ketotifen | |
| Systematic (IUPAC) name | |
| 4,9-dihydro-4-(1-methyl-4-piperidinylidene)- 10H-benzocyclohepta[1,2-b]thiopen-10-one | |
| Identifiers | |
| CAS number | 34580-14-8 |
| ATC code | R06AX17 S01GX08 |
| PubChem | 3827 |
| DrugBank | APRD01061 |
| Chemical data | |
| Formula | C19H19NOS |
| Mol. weight | 309.426 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 60% |
| Protein binding | 75% |
| Metabolism | Hepatic |
| Half life | 21 Hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | Oral |
Ketotifen fumarate (sold under the brand name Zaditor) is an H1-antihistamine available in two forms. In its ophthalmic form, it is used to treat allergic conjunctivitis, or the itchy red eyes caused by allergies. In its oral form, it is used to prevent asthma attacks. Side effects include drowsiness, weight gain, dry mouth, irritability, and increased nosebleeds.

Not Signed In - 


